Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.130
-0.020 (-1.74%)
At close: Apr 28, 2026, 4:00 PM EDT
1.122
-0.008 (-0.74%)
After-hours: Apr 28, 2026, 7:46 PM EDT

Entera Bio Statistics

Total Valuation

Entera Bio has a market cap or net worth of $51.75 million. The enterprise value is $45.13 million.

Market Cap 51.75M
Enterprise Value 45.13M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, after market close.

Earnings Date May 14, 2026
Ex-Dividend Date n/a

Share Statistics

Entera Bio has 46.62 million shares outstanding. The number of shares has increased by 22.69% in one year.

Current Share Class 46.62M
Shares Outstanding 46.62M
Shares Change (YoY) +22.69%
Shares Change (QoQ) +0.39%
Owned by Insiders (%) 2.65%
Owned by Institutions (%) 12.18%
Float 32.09M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1,232.16
Forward PS n/a
PB Ratio 3.91
P/TBV Ratio 3.95
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1,074.59
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 6.94, with a Debt / Equity ratio of 0.04.

Current Ratio 6.94
Quick Ratio 3.33
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -108.01% and return on invested capital (ROIC) is -65.68%.

Return on Equity (ROE) -108.01%
Return on Assets (ROA) -56.78%
Return on Invested Capital (ROIC) -65.68%
Return on Capital Employed (ROCE) -83.60%
Weighted Average Cost of Capital (WACC) 12.62%
Revenue Per Employee $1,909
Profits Per Employee -$519,955
Employee Count 22
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -52.92% in the last 52 weeks. The beta is 1.54, so Entera Bio's price volatility has been higher than the market average.

Beta (5Y) 1.54
52-Week Price Change -52.92%
50-Day Moving Average 1.26
200-Day Moving Average 1.83
Relative Strength Index (RSI) 44.13
Average Volume (20 Days) 230,557

Short Selling Information

The latest short interest is 192,781, so 0.41% of the outstanding shares have been sold short.

Short Interest 192,781
Short Previous Month 175,306
Short % of Shares Out 0.41%
Short % of Float 0.60%
Short Ratio (days to cover) 1.08

Income Statement

In the last 12 months, Entera Bio had revenue of $42,000 and -$11.44 million in losses. Loss per share was -$0.25.

Revenue 42,000
Gross Profit n/a
Operating Income -11.53M
Pretax Income -11.44M
Net Income -11.44M
EBITDA -11.50M
EBIT -11.53M
Loss Per Share -$0.25
Full Income Statement

Balance Sheet

The company has $7.11 million in cash and $490,000 in debt, giving a net cash position of $6.62 million or $0.14 per share.

Cash & Cash Equivalents 7.11M
Total Debt 490,000
Net Cash 6.62M
Net Cash Per Share $0.14
Equity (Book Value) 13.10M
Book Value Per Share 0.28
Working Capital 13.10M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.37 million and capital expenditures -$107,000, giving a free cash flow of -$7.48 million.

Operating Cash Flow -7.37M
Capital Expenditures -107,000
Depreciation & Amortization 30,000
Net Borrowing n/a
Free Cash Flow -7.48M
FCF Per Share -$0.16
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -27,450.00%
Pretax Margin -27,235.71%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Entera Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -22.69%
Shareholder Yield -22.69%
Earnings Yield -22.10%
FCF Yield -14.45%

Analyst Forecast

The average price target for Entera Bio is $9.00, which is 696.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.00
Price Target Difference 696.46%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Entera Bio has an Altman Z-Score of 6.72 and a Piotroski F-Score of 1.

Altman Z-Score 6.72
Piotroski F-Score 1